ANI PHARMACEUTICALS, INC Financing Cash Flow
ANI PHARMACEUTICALS, INC (ANIP) reported Financing Cash Flow of -$26.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$4.65M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$21.62M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$4.64M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $6.34M, a 97.82% decline year-over-year.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2025 was -$9.94M, a 103.75% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2024 was $264.94M, a 292.87% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2023 was $67.44M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2022 was -$5.13M, a 102.63% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$26.26M 10-Q · filed 2026-08-07 | -$30.90M derived: sum of 3 quarters · filed 2026-08-07 | -$24.55M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | -$21.62M 10-Q · filed 2026-05-08 | -$26.25M derived: sum of 2 quarters · filed 2026-05-08 | -$19.91M derived: sum of 3 quarters · filed 2026-05-08 | -$21.65M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.71M derived: sum of 2 quarters · filed 2026-02-27 | -$38.00K derived: sum of 3 quarters · filed 2026-08-07 | -$9.94M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.60M derived: sum of 2 quarters · filed 2026-08-07 | -$5.31M 10-Q · filed 2025-11-07 | -$10.21M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$11.65M 10-Q · filed 2026-08-07 | -$16.56M derived: sum of 3 quarters · filed 2026-08-07 | $274.47M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | -$9.91M 10-Q · filed 2026-05-08 | -$14.81M derived: sum of 2 quarters · filed 2026-05-08 | $276.22M derived: sum of 3 quarters · filed 2026-05-08 | $274.76M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | -$4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $286.12M derived: sum of 2 quarters · filed 2026-02-27 | $284.67M derived: sum of 3 quarters · filed 2026-02-27 | $264.94M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $291.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $289.58M derived: sum of 2 quarters · filed 2025-11-07 | $269.85M 10-Q · filed 2025-11-07 | $257.93M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$21.18M 10-Q · filed 2025-08-08 | -$33.10M derived: sum of 3 quarters · filed 2026-02-27 | -$29.34M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | -$19.73M 10-Q · filed 2025-05-09 | -$31.64M derived: sum of 2 quarters · filed 2026-02-27 | -$27.89M derived: sum of 3 quarters · filed 2026-02-27 | $52.26M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | -$11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$8.16M derived: sum of 2 quarters · filed 2026-02-27 | $71.99M derived: sum of 3 quarters · filed 2026-02-27 | $67.44M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $83.91M derived: sum of 2 quarters · filed 2024-11-08 | $79.36M 10-Q · filed 2024-11-08 | $78.85M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $80.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $75.60M 10-Q · filed 2024-08-06 | $75.09M derived: sum of 3 quarters · filed 2025-02-28 | $74.18M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | -$4.55M 10-Q · filed 2024-05-10 | -$5.06M derived: sum of 2 quarters · filed 2025-02-28 | -$5.97M derived: sum of 3 quarters · filed 2025-02-28 | -$7.40M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | -$508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.42M derived: sum of 2 quarters · filed 2025-02-28 | -$2.86M derived: sum of 3 quarters · filed 2025-02-28 | -$5.13M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$911.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.35M derived: sum of 2 quarters · filed 2023-11-08 | -$4.62M 10-Q · filed 2023-11-08 | $174.83M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$3.71M 10-Q · filed 2023-08-09 | $175.74M derived: sum of 3 quarters · filed 2024-02-29 | $172.72M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$2.27M 10-Q · filed 2023-05-08 | $177.17M derived: sum of 2 quarters · filed 2024-02-29 | $174.15M derived: sum of 3 quarters · filed 2024-02-29 | $195.05M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $179.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $176.42M derived: sum of 2 quarters · filed 2024-02-29 | $197.32M derived: sum of 3 quarters · filed 2024-02-29 | $194.59M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $17.88M derived: sum of 2 quarters · filed 2022-11-09 | $15.15M 10-Q · filed 2022-11-09 | $12.94M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $20.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $18.17M 10-Q · filed 2022-08-08 | $15.96M derived: sum of 3 quarters · filed 2023-03-09 | $13.59M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | -$2.73M 10-Q · filed 2022-05-10 | -$4.93M derived: sum of 2 quarters · filed 2023-03-09 | -$7.31M derived: sum of 3 quarters · filed 2023-03-09 | -$18.05M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$4.59M derived: sum of 2 quarters · filed 2023-03-09 | -$15.33M derived: sum of 3 quarters · filed 2023-03-09 | -$1.44M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$13.12M derived: sum of 2 quarters · filed 2021-11-01 | $769.00K 10-Q · filed 2021-11-01 | $3.00K derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-06-30 | -$10.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.15M 10-Q · filed 2021-08-06 | $2.38M derived: sum of 3 quarters · filed 2022-03-15 | $1.61M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-03-31 | $13.89M 10-Q · filed 2021-05-07 | $13.13M derived: sum of 2 quarters · filed 2022-03-15 | $12.36M derived: sum of 3 quarters · filed 2022-03-15 | $13.94M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2019-12-31 | -$766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$1.54M derived: sum of 2 quarters · filed 2022-03-15 | $44.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.25M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | -$770.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $810.00K derived: sum of 2 quarters · filed 2020-11-05 | $2.02M 10-Q · filed 2020-11-05 | -$25.93M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.79M 10-Q · filed 2020-08-06 | -$25.16M derived: sum of 3 quarters · filed 2021-03-11 | -$25.89M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-03-31 | $1.21M 10-Q · filed 2020-05-07 | -$26.74M derived: sum of 2 quarters · filed 2021-03-11 | -$27.47M derived: sum of 3 quarters · filed 2021-03-11 | -$26.78M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | -$27.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$28.68M derived: sum of 2 quarters · filed 2021-03-11 | -$27.99M derived: sum of 3 quarters · filed 2021-03-11 | -$27.82M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | -$731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$40.00K derived: sum of 2 quarters · filed 2019-11-06 | $130.00K 10-Q · filed 2019-11-06 | $47.55M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $861.00K 10-Q · filed 2019-08-07 | $48.29M derived: sum of 3 quarters · filed 2020-02-27 | $43.35M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $170.00K 10-Q · filed 2019-05-09 | $47.59M derived: sum of 2 quarters · filed 2020-02-27 | $42.66M derived: sum of 3 quarters · filed 2020-02-27 | $42.50M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $47.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $42.48M derived: sum of 2 quarters · filed 2020-02-27 | $42.33M derived: sum of 3 quarters · filed 2020-02-27 | $72.36M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | -$4.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$5.09M derived: sum of 2 quarters · filed 2018-11-06 | $24.93M 10-Q · filed 2018-11-06 | $25.45M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $29.87M 10-Q · filed 2018-08-07 | $30.39M derived: sum of 3 quarters · filed 2019-02-27 | $31.54M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $30.02M 10-Q · filed 2018-05-08 | $30.54M derived: sum of 2 quarters · filed 2019-02-27 | $31.69M derived: sum of 3 quarters · filed 2019-02-27 | $31.65M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.66M derived: sum of 2 quarters · filed 2019-02-27 | $1.63M derived: sum of 3 quarters · filed 2019-02-27 | -$729.00K 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.11M derived: sum of 2 quarters · filed 2017-11-02 | -$1.25M 10-Q · filed 2017-11-02 | -$1.07M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$2.39M 10-Q · filed 2017-08-03 | -$2.22M derived: sum of 3 quarters · filed 2018-02-27 | -$1.50M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | -$2.35M 10-Q · filed 2017-05-04 | -$2.18M derived: sum of 2 quarters · filed 2018-02-27 | -$1.47M derived: sum of 3 quarters · filed 2018-02-27 | -$1.31M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $888.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.05M derived: sum of 3 quarters · filed 2018-02-27 | $1.07M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $874.00K derived: sum of 2 quarters · filed 2015-11-03 | $892.00K 10-Q · filed 2015-11-03 | $124.48M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-06-30 | $160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $178.00K 10-Q · filed 2015-08-04 | $123.76M derived: sum of 3 quarters · filed 2017-03-02 | $124.22M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-03-31 | $18.00K 10-Q · filed 2015-05-05 | $123.60M derived: sum of 2 quarters · filed 2017-03-02 | $124.06M derived: sum of 3 quarters · filed 2017-03-02 | $123.95M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $123.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $124.04M derived: sum of 2 quarters · filed 2017-03-02 | $123.93M derived: sum of 3 quarters · filed 2017-03-02 | $171.65M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $458.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $345.00K derived: sum of 2 quarters · filed 2015-11-03 | $48.07M 10-Q · filed 2015-11-03 | $48.88M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $47.61M 10-Q · filed 2015-08-04 | $48.42M derived: sum of 3 quarters · filed 2016-02-23 | $48.42M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $47.72M 10-Q · filed 2015-05-05 | $48.53M derived: sum of 2 quarters · filed 2016-02-23 | $48.53M derived: sum of 3 quarters · filed 2016-02-23 | $43.66M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $809.00K derived: sum of 2 quarters · filed 2016-02-23 | -$4.06M derived: sum of 3 quarters · filed 2016-02-23 | -$3.69M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$4.87M derived: sum of 2 quarters · filed 2014-11-10 | -$4.50M 10-Q · filed 2014-11-10 | -$4.50M 10-Q · filed 2013-11-07 | -$3.86M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | -$4.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$4.50M 10-Q · filed 2014-08-07 | -$4.50M 10-Q · filed 2013-08-09 | -$3.86M derived: sum of 3 quarters · filed 2014-08-07 | -$3.69M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $372.00K 10-Q · filed 2014-05-12 | $1.01M derived: sum of 2 quarters · filed 2014-05-12 | $1.18M derived: sum of 3 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $636.39K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $807.18K derived: sum of 2 quarters · filed 2014-02-28 | $440.00K 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $170.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$196.39K 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | -$367.18K 10-Q · filed 2013-08-09 | |||||
| 2011-09-30 | $45.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $69.04M 10-Q · filed 2011-11-09 | ||||
| 2011-06-30 | $23.88M 10-Q · filed 2011-08-05 | |||||
| 2010-09-30 | -$264.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $31.59M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $31.59M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |